PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT)
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is an open label controlled household-randomised trial designed to evaluate the efficacy
of RESP301 alongside standard of care ("SOC") versus SOC alone.